Special Populations and Pharmacogenetic Issues in Tuberculosis Drug Development and Clinical Research

Special populations, including children and pregnant women, have been neglected in tuberculosis drug development. Patients in developing countries are inadequately represented in pharmacology research, and postmarketing pharmacovigilance activities tend to be rudimentary in these settings. There is...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Infect Dis
Main Authors: McIlleron, Helen, Abdel-Rahman, Susan, Dave, Joel Alex, Blockman, Marc, Owen, Andrew
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
Tuberculosis Drug Development: Towards a Critical Path for Developing New Regimens to Treat Tuberculosis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4551115/
https://ncbi.nlm.nih.gov/pubmed/26009615
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiu600
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados